Literature DB >> 27314266

Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt.

Tsutomu Murakami1, Gaku Nakazawa2, Hitomi Horinouchi1, Sho Torii1, Takeshi Ijichi1, Yohei Ohno1, Mari Amino1, Norihiko Shinozaki1, Nobuhiko Ogata1, Fuminobu Yoshimachi1, Koichiro Yoshioka1, Yuji Ikari1.   

Abstract

A 56-year-old woman was diagnosed as atrial septal defect (ASD) with pulmonary hypertension; pulmonary blood flow/systemic blood flow (Qp/Qs) of 2.3, pulmonary artery pressure (PAP) of 71/23(39) mmHg and diastolic dysfunction of left ventricle. PAP was improved after medical therapy; therefore, transcatheter ASD closure was performed. Seven days later, left-sided heart failure occurred, however, the improvement of Qp/Qs (1.7) and PAP of 51/21(32) was confirmed. Diuretic therapy was introduced which led to further decrease of PAP 40/12(25) and Qp/Qs (1.1). Because of gradual decrease of Qp/Qs, this patient appeared to be protected from acute pulmonary edema.

Entities:  

Keywords:  Atrial septal defect; Pulmonary artery hypertension; Pulmonary edema; Transcatheter closure

Mesh:

Substances:

Year:  2016        PMID: 27314266     DOI: 10.1007/s00380-016-0863-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  13 in total

1.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

2.  Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.

Authors:  Zhen-Ning Zhang; Xin Jiang; Rui Zhang; Xin-Li Li; Bing-Xiang Wu; Qin-Hua Zhao; Yong Wang; Li-Zhi Dai; Lei Pan; Mardi Gomberg-Maitland; Zhi-Cheng Jing
Journal:  Heart       Date:  2011-09-21       Impact factor: 5.994

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary.

Authors:  Candice K Silversides; Ariane Marelli; Luc Beauchesne; Annie Dore; Marla Kiess; Omid Salehian; Timothy Bradley; Jack Colman; Michael Connelly; Louise Harris; Paul Khairy; Seema Mital; Koichiro Niwa; Erwin Oechslin; Nancy Poirier; Markus Schwerzmann; Dylan Taylor; Isabelle Vonder Muhll; Helmut Baumgartner; Lee Benson; David Celermajer; Matthias Greutmann; Eric Horlick; Mike Landzberg; Folkert Meijboom; Barbara Mulder; Carole Warnes; Gary Webb; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

4.  Abnormal left heart function after operation for atrial septal defect.

Authors:  H Davies; G C Oliver; W J Rappoport; N Gazetopoulos
Journal:  Br Heart J       Date:  1970-11

5.  [Acute left heart failure following repair of atrial septal defects. Its treatment by reopening].

Authors:  J Beyer; L Brunner; W Hügel; E Kreuzer; B Reichart; L Sunder-Plassmann; W Klinner
Journal:  Thoraxchir Vask Chir       Date:  1975-08

6.  Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.

Authors:  S Schubert; B Peters; H Abdul-Khaliq; N Nagdyman; P E Lange; P Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2005-03       Impact factor: 2.692

7.  Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Anna Correra; Giuseppe Santoro; Gianpiero Gaio; Berardo Sarubbi; Raffaele Calabrò; Maria Giovanna Russo
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

8.  Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure?

Authors:  P Ewert; F Berger; N Nagdyman; O Kretschmar; S Dittrich; H Abdul-Khaliq; P Lange
Journal:  Catheter Cardiovasc Interv       Date:  2001-02       Impact factor: 2.692

9.  The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.

Authors:  Aya Miyazaki; Heima Sakaguchi; Hideo Ohuchi; Kenji Yasuda; Nobuyuki Tsujii; Michio Matsuoka; Tetsuya Yamamoto; Satoshi Yazaki; Etsuko Tsuda; Osamu Yamada
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

10.  Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports : strategy for ASD with severe PAH.

Authors:  Yu Taniguchi; Noriaki Emoto; Kazuya Miyagawa; Kazuhiko Nakayama; Hiroto Kinutani; Hidekazu Tanaka; Toshiro Shinke; Kenji Okada; Yutaka Okita; Ken-ich Hirata
Journal:  Heart Vessels       Date:  2013-04-18       Impact factor: 2.037

View more
  3 in total

1.  Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation.

Authors:  Tomonori Watanabe; Shinsuke Miyazaki; Takatsugu Kajiyama; Sadamitsu Ichijo; Takamitsu Takagi; Miyako Igarashi; Hiroaki Nakamura; Hiroshi Taniguchi; Hitoshi Hachiya; Yoshito Iesaka
Journal:  Heart Vessels       Date:  2018-03-17       Impact factor: 2.037

2.  Totally Endoscopic Cardiac Surgery for Atrial Septal Defect Repair on Beating Heart Without Robotic Assistance in 25 Patients.

Authors:  Quang-Huy Dang; Ngoc-Thanh Le; Cong-Huu Nguyen; Dac-Dai Tran; Do-Hung Nguyen; Trung-Hieu Nguyen; Thi-Hai-Linh Ngo
Journal:  Innovations (Phila)       Date:  2017 Nov/Dec

3.  Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.

Authors:  Yoichi Takaya; Teiji Akagi; Ichiro Sakamoto; Hideaki Kanazawa; Gaku Nakazawa; Tsutomu Murakami; Atsushi Yao; Mamoru Nanasato; Mike Saji; Mitsugu Hirokami; Yasushi Fuku; Shinobu Hosokawa; Norio Tada; Kensuke Matsumoto; Masao Imai; Koji Nakagawa; Hiroshi Ito
Journal:  Heart       Date:  2021-06-15       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.